Jennifer A Bryant
Overview
Explore the profile of Jennifer A Bryant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee C, Chan R, Toh D, Kui M, Lee V, Bryant J, et al.
JACC Asia
. 2025 Mar;
5(3 Pt 1):350-357.
PMID: 40049926
Background: Left ventricular hypertrophy (LVH) is a strong predictor of adverse outcomes. Although normalizing LV mass (LVM) to height exponents reduced variability from body size, specific recommendations for height exponents...
2.
Iyer N, Bryant J, Le T, Grenier J, Thompson R, Chin C, et al.
Eur Heart J Imaging Methods Pract
. 2024 Sep;
2(3):qyae089.
PMID: 39296919
Aims: Non-invasive methods to quantify pulmonary congestion are lacking in clinical practice. Cardiovascular magnetic resonance (CMR) lung water density (LWD) mapping is accurate and reproducible and has prognostic value. However,...
3.
Lee V, Han Y, Toh D, Bryant J, Boubertakh R, Le T, et al.
Front Endocrinol (Lausanne)
. 2024 Sep;
15:1439691.
PMID: 39257902
Background: Heterogenous deposition and homeostasis roles of physiologic and ectopic adipose tissues underscore the impact of fat compartmentalization on cardiometabolic risk. We aimed to characterize the distribution of abdominal visceral...
4.
Iyer N, Chan S, Liew O, Chong J, Bryant J, Le T, et al.
BMC Cardiovasc Disord
. 2024 Mar;
24(1):141.
PMID: 38443793
Background: Heart failure (HF) and diabetes are associated with increased incidence and worse prognosis of each other. The prognostic value of global longitudinal strain (GLS) measured by cardiovascular magnetic resonance...
5.
Lee V, Zheng Q, Toh D, Pua C, Bryant J, Lee C, et al.
Front Cardiovasc Med
. 2023 Sep;
10:1248468.
PMID: 37674806
Background: Diffuse interstitial myocardial fibrosis is a key common pathological manifestation in hypertensive heart disease (HHD) progressing to heart failure (HF). Angiotensin receptor-neprilysin inhibitors (ARNi), now a front-line treatment for...
6.
Pua C, Loo G, Kui M, Moy W, Hii A, Lee V, et al.
Circ Cardiovasc Imaging
. 2023 Jul;
16(7):545-553.
PMID: 37431660
Background: Compared with patients with hypertension only, those with hypertension and diabetes (HTN/DM) have worse prognosis. We aimed to characterize morphological differences between hypertension and HTN/DM using cardiovascular magnetic resonance;...
7.
Iyer N, Le T, Kui M, Tang H, Chin C, Phua S, et al.
Hypertension
. 2022 May;
79(8):1804-1813.
PMID: 35603595
Background: The prognostic significance of focal and diffuse myocardial fibrosis in patients with cardiovascular risk factors is unclear. Methods: REMODEL (Response of the Myocardium to Hypertrophic Conditions in the Adult...
8.
Chua J, Le T, Sim Y, Chye H, Tan B, Yao X, et al.
J Am Heart Assoc
. 2022 Mar;
11(6):e024226.
PMID: 35253475
Background This study examined the associations between quantitative optical coherence tomography angiography (OCTA) parameters and myocardial abnormalities as documented on cardiovascular magnetic resonance imaging in patients with systemic hypertension. Methods...
9.
Le T, Huang W, Singh G, Toh D, Ewe S, Tang H, et al.
Front Cardiovasc Med
. 2021 Dec;
8:750016.
PMID: 34859068
Left ventricular ejection fraction is the conventional measure used to guide heart failure management, regardless of underlying etiology. Left ventricular global longitudinal strain (LV-GLS) by speckle tracking echocardiography (STE) is...
10.
Tromp J, Bryant J, Jin X, van Woerden G, Asali S, Yiying H, et al.
Eur J Heart Fail
. 2021 Mar;
23(5):835-838.
PMID: 33724596
No abstract available.